Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinomas patients with EGFR mutations. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback